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Blood-injection-injury (BII) phobia is associated with avoidance of needed medical treatment.  
Exposure therapy lessens distress related to viewing BII stimuli. However, many clinicians 
report difficulty with clients not completing exposure therapy. This study assessed whether the 
peak-end rule of memory could be manipulated to encourage the acceptability of and lessen the 
distress associated with exposures to BII stimuli. 201 participants recruited via Amazon.com’s 
MTurk were randomly assigned to view or not view a series of less distressing photos of BII at 
the end of an exposure session to BII stimuli. Participants who viewed the less distressing photos 
at the end of the exposure session rated it retrospectively less distressing overall. The results 
suggest promise for using the peak-end rule to improve exposure therapy outcomes for clients 
with BII phobia. 












Table of Contents 
Acceptance Page ………………………………………………………………………………….ii 
Abstract …………………………………………………………………………………………..iii 
Table of Contents ………………………………………………………………………………...iv 
Introduction ……………………………………………………………………………………….1 
 Exposure Therapy…………………………………………………....................................3 
Exposure to BII Stimuli.………………………………………………………..................6 
 Peak-End Rule…………………………………………………………………...............11 
 Present Study..…………………………………………………………………...............17 
Methods…………………………………………………………………………………………..19 
 Participants……………………………………………………………………………….19 
 Sample Size Calculation…………………………………………………………………19 
 Procedures………………………………………………………………..………………20 
 Measures…………………………………………………………………………………21 
  Demographic data………………….…………………………………………….21 
  Medical Fear Survey-Short Version……………………………………………..21 
  Pre-viewing distress……………………………………………………………...21 
  Average distress for first 15 images……………………………………………...21 
  Primary outcome measure: Retrospective global assessment of distress………..22 
Secondary outcome measure: Willingness to complete hypothetical second 
session……………………………………………………………………………22  




Exploratory outcome measure: Current distress…………………………………22 
Results……………………………………………………………………………………………22 
 Demographics…………………………………………………………………………....22 
 Baseline comparison……………………………………………………………………..22 
 Average distress for first 15 images……………………………………………...............23 
  Primary outcome measure: Retrospective global assessment of distress………..23 
Secondary outcome measure: Willingness to complete hypothetical second 
session……………………………………………………………………………23  
Secondary outcome measure: Payment required for hypothetical second 
session……………………………………………………………………………23 




 Table 1: Procedures for Groups 1 and 2………………………………………………....32  
Table 2: Demographic Data…………………..………………………………………….33 
Table 3: Baseline Data…………………………………………………………………...34 
Table 4: Average Distress for First 15 Images…………………………………………..35 
Table 5: Outcome Data………………………..…………………………………………36 
1 
 
A “Better End” to Exposure? Assessing the Effects of the Peak-End Rule on Viewing Blood-
Injection-Injury Stimuli 
The lifetime prevalence rate of specific phobia, blood-injection-injury (BII) type, or BII 
phobia, is 3.5% among the general population (Bienvenu & Eaton, 1998). According to the 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, or DSM-5 (American 
Psychiatric Association, 2013), those affected by BII phobia are excessively fearful of blood, 
injuries, or injections, or some combination of the three. People with BII phobia are particularly 
fearful of fainting upon viewing the phobic stimuli (Öst, 1992); consequently, they frequently 
avoid them (American Psychiatric Association, 2013).     
BII avoidance increases nonadherence to medical regimens among persons with diabetes, 
multiple sclerosis, and other chronic medical conditions (Cox & Mohr, 2003). For example, 
Zambanini et al. (1999) examined anxiety related to injection at a diabetes care clinic among 115 
patients who required daily self-injections of insulin. Participants with either Type 1 or Type 2 
diabetes completed questionnaires pertaining to their injection anxiety, general anxiety, and 
injection regimen (e.g., number of daily injections). Researchers found a significant negative 
correlation between injection anxiety score and number of daily injections. Participants with high 
scores relating to injection anxiety were significantly less likely than participants with low scores 
to inject once or twice daily, significantly more likely to avoid injections, and significantly more 
likely to indicate concern about the prospect of injecting more frequently.  
Similarly, Mollema et al. (2001) examined the relationship between diabetes management 
and fear of self-injection of insulin or self-testing of blood glucose among a sample of 1275 adult 
patient members of the Dutch Diabetes Association. They completed a survey assessing fear of 
injection, fear of self-testing, diabetes related behaviors, other mental health attributes (e.g., 
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state/trait anxiety), and general well-being. The researchers compared scores of participants who 
scored at the 95th percentile or higher in fear of self-injection or self-testing with participants 
who scored below this mark. Those in the higher-scoring group reported overall lower well-
being and greater mental health difficulties. Most importantly, they also indicated that they 
checked their blood glucose levels significantly less frequently: 61% checked less than five times 
per week compared to 45.5% who checked at that rate in the lower-scoring group. 
In addition to negatively affecting medical action for chronic conditions, BII phobia also 
contributes to avoidance of pursuing standard medical care. Poulton et al. (1998) examined the 
effect of a fear of blood or injections on dental care. Participants were 18-year old New Zealand 
residents whose health data were collected as part of a longitudinal study. Of 936 total 
individuals, 96 reported a fear of visiting the dentist, and 52 of these 96 reported a comorbid fear 
of either blood or injections. The researchers compared oral health among individuals in four 
groups: dental fear alone, blood or injection fear alone, comorbid dental and blood or injection 
fear, and no dental, blood or injection fear (the control group). They found that participants with 
a comorbid blood or injection and dental fear had significantly worse oral health outcomes than 
the no fear group. Additionally, participants in the comorbid group had experienced tooth decay 
more recently than those with dental fear alone. They also reported the longest time since their 
last dental visit of any of the groups. The data suggest that fear of blood or injections may 
exacerbate poor outcomes among those already predisposed to avoiding the dentist. 
Part of standard medical care involves regular appointments with physicians and dentists. 
BII phobia may prevent individuals from making or keeping appointments due to a fear of 
coming into contact with BII stimuli. Kleinknecht and Lenz (1989) collected information from 
university students regarding fears of blood or injury and fainting behaviors in response to seeing 
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them. Based on their histories, 103 participants were classified as fainters and 101 as non-
fainters. Participants were divided into four categories prior to analysis: phobic fainters, fearful 
fainters, fearful non-fainters, and non-fearful fainters. Phobic and fearful fainters were 
significantly more likely to report past avoidance of and future intentions to avoid appointments 
with physicians. Additionally, they indicated they were more likely to avoid appointments with 
dentists. 
The weight of the evidence indicates that BII phobia causes or exacerbates medical 
avoidance and worsens physical health outcomes. As such, treatment of it via exposure therapy 
may be associated with improved health outcomes. 
Exposure Therapy 
In general, the most efficacious treatments for specific phobias are exposure-based (Grös 
& Antony, 2006; Wolitzky-Taylor et al., 2008). They involve controlled, repeated exposure to 
the feared stimulus. Through systematic exposure, the individual habituates to the stimulus. 
Wolitzky-Taylor et al. (2008) conducted a meta-analysis of 33 randomized controlled trials of 
psychological treatments for specific phobias. Treatments were classified as exposure-based 
(e.g., in vivo exposure, imaginal exposure, virtual reality exposure), non-exposure-based (e.g., 
cognitive therapy without an exposure component, progressive muscle relaxation), placebo (e.g., 
watching a nature film, pleasant imagery), or no treatment (i.e., waitlist control). The analysis 
indicated that individuals receiving a psychological treatment fared significantly better on 
behavioral and self-report outcome measures than approximately 85% of individuals not 
receiving treatment.  Among those receiving treatment, exposure therapies were significantly 
more effective than non-exposure-based therapies and placebos. 
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Several studies support exposure-based therapy as an efficacious treatment for BII 
phobia. Olatunji et al. (2007) found that 30 minutes of exposure to BII stimuli significantly 
reduced levels of fear in participants. Other studies have arrived at similar results (e.g., Hirai et 
al., 2008; Öst, Hellström & Kåver, 1992). Like any therapy, however, the benefits of the 
treatment depend on clients completing therapeutic regimens as opposed to terminating treatment 
prematurely.     
One of the difficulties with exposure therapy is convincing persons to undergo the actual 
exposures. Patients are accustomed to fearing and avoiding the stimulus to which they are meant 
to be exposed. Exposures typically must be carried out over many weeks of treatment. Helping a 
patient to complete repeated exposures is a challenge for many clinicians (Franklin, Riggs, & 
Pai, 2005; Leahy, 2007). Investigations regarding how people remember unpleasant events could 
inform clinicians’ strategies for encouraging clients to undergo exposures. 
Research on remembered utility (that is, “a subject’s own global evaluation of a past 
episode” [Kahneman, 2000]) yields two counter-intuitive findings about memories of distress 
(Redelmeier & Kahneman, 1996). The first concerns duration neglect: the length of a distressing 
event has little to no effect on one’s retrospective evaluation of the amount of distress one 
experienced during the event (Kahneman et al, 1993). The second concerns the peak-end rule: a 
person’s evaluation of how distressing a past experience was derives from an unweighted 
average of the most intense distress experienced during an event (the peak) with the amount of 
distress experienced at the event’s conclusion (the end) (Fredrickson & Kahneman, 1993). 
Studies support duration neglect and the peak-end rule’s centrality to remembered utility 
(Fredrickson & Kahneman, 1993; Schreiber & Kahneman, 2000; Varey & Kahneman, 1992). 
Research also demonstrates that the peak-end rule applies to medicinal domains, including 
5 
 
participants’ evaluations of colonoscopies (Redelmeier, Katz, & Kahneman, 2003) and 
physically painful experiences (Kahneman et al., 1993).One can understand the potential 
influence of the peak-end in psychotherapy within the context of a hypothetical exposure 
treatment. Per the peak-end rule, a hypothetical patient, Anita’s, overall assessment of the 
distress of an exposure therapy session would be determined by the most distressing moment of 
the session (the peak) averaged with the distress she experienced at the close of the session (the 
end). 
Data related to the peak-end rule could inform the use of exposure therapy and favorably 
improve clients’ evaluations of the procedure. For example, Anita’s clinician, knowing that her 
clients often experience difficulty with completing repeated exposure sessions, could structure 
sessions to decrease the distress experienced at their conclusion. This might improve Anita’s 
retrospective evaluation of the distress experienced in each session. For instance, if Anita rated 
her peak distress during an exposure session as a 9 on a 10-point Subjective Units of Distress 
(SUDs; Wolpe, 1969) scale, and her distress at the end of a session as a 7, she should remember 
the distress of the session as an unweighted average of the two numbers: an 8 in SUDs. 
Alternatively, if Anita’s clinician took care to decrease the distress experienced at the end of the 
session, Anita might rate the end as a 3. Averaged with her peak rating of a 9, this would 
decrease the overall amount of distress she remembers experiencing to a 6 in SUDs. 
Remembering the session as a 6 instead of an 8 in SUDS might encourage Anita to continue with 
therapy when she would otherwise quit.  
This research aims to synthesize literature on exposure therapy for BII phobia with 
findings concerning the peak-end rule. First, studies on exposure to BII stimuli will be reviewed. 
Next, studies exemplifying the role of the peak-end rule in determining evaluations of medical 
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procedures and related stimuli (e.g., pain) will be discussed. Finally, some strategies for utilizing 
the peak-end rule to improve the acceptability of exposure therapy to BII stimuli will be 
proposed, and an original empirical study based on these strategies conducted and reviewed.  
Exposure to BII Stimuli 
Traditional accounts of BII phobia focus on fear and anxiety associated with BII stimuli 
as the primary causes and maintaining factors of the disorder.1 For persons with BII phobia, the 
fear and anxiety are closely linked with fainting. A person with BII phobia confronting a feared 
stimulus typically experiences a diphasic response: first, an increase in blood pressure and heart 
rate, symptomatic of anxiety and observed in other anxiety disorders and simples phobias (Öst, 
Sterner, & Lindahl, 1984b). This is followed by a sharp decrease below baseline in blood 
pressure and heart rate, a physiological change unique to BII phobia (Öst, Sterner, & Lindahl, 
1984b). The decrease in blood pressure and heart rate may result in the person with BII phobia 
fainting. Consequently, the person with BII phobia fears the prospect of fainting again (Öst, 
Sterner, & Lindahl, 1984b), and attempts to lessen the chances of fainting occurring by avoiding 
BII stimuli (American Psychiatric Association, 2013). Proponents of exposure therapy contend 
that by using exposure to lessen the anxiety-driven increase in blood pressure and heart rate that 
comprise the first part of the diphasic response, the entire response will be arrested, no further 
fainting will occur in the presence of BII stimuli, and subsequent fear and avoidance of the 
stimuli will decrease (Öst et al., 1984a). 
                                                          
1 Recent evidence suggests that disgust plays a role in the etiology and maintenance of BII phobia (see Olatunji et 
al., 2012a, for a review). However, exposure to disgusting stimuli is not a necessary component of exposure therapy 
for BII phobia, nor is it clear if it provides benefit beyond mere exposure to feared stimuli (Hirai et al., 2008, 
Olatunji et al., 2007; see Williams, 2014, for a review). As such, the present manuscript principally concerns itself 
with the role of fear in BII phobia and the body of research indicating the benefit of exposure to it (e.g., Öst, 
Hellström, & Kåver, 1992).  
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Early research assessing the efficacy of exposure protocols for BII centered on the work 
of Lars-Göran Öst and colleagues. Previous literature on behavioral treatments of BII involved 
single-subject designs (e.g., Cohn, Kron, & Brady, 1976; Yule & Fernando, 1980) or were 
primarily intended to explore a theoretical question regarding a particular behavioral treatment 
(e.g., demand characteristics in systematic desensitization; McReynolds & Tori, 1972) as 
opposed to treating BII phobia (Öst et al., 1984a). Öst was the first researcher to investigate 
exposure treatments for BII stimuli in controlled group trials. 
The initial controlled group exposure study for a component of BII phobia compared nine 
sessions of exposure with nine sessions of training in applied relaxation in the treatment of 
individuals with blood phobia (Öst et al., 1984a). The exposure component consisted of mere 
exposure to blood stimuli (e.g., watching someone give blood), while the applied relaxation 
component consisted of coaching in progressive muscle relaxation and applied tension (tensing 
and releasing the arms, legs, and torso muscles for the purpose of increasing blood pressure). 
Participants in the latter condition were taught to use progressive muscle relaxation and applied 
tension when confronting the blood stimuli. Eighteen participants from a psychiatric hospital 
were randomized to participate in either exposure or applied relaxation training. After 
participating in treatment, participants completed self-report measure of fear of blood as well as 
physiological and behavioral measures. The physiological measures tracked participants’ post-
treatment heart rates and blood pressure upon viewing blood stimuli. The behavioral measures 
consisted of a time measurement (zero to 30 minutes) of how long a participant could watch a 
video consisting of blood stimuli, and a 0-4 Likert scale measurement completed by a trained 
therapist of participants’ fainting behavior (ranging from no fainting reactions to participants 
actually fainting). The nine participants in the exposure to blood stimuli condition self-reported 
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less distress than nine participants in the applied relaxation coaching condition. There were no 
statistically significant differences between the groups on the physiological and behavioral 
measures. The results indicate that exposure therapy is slightly preferable to applied relaxation in 
the treatment of blood phobia. 
Following research indicating that applied tension by itself yielded more impressive 
blood phobia treatment results than the applied relaxation treatment package (consisting of 
applied tension combined with progressive muscle relaxation) (Öst, Sterner, & Fellenius, 1989), 
Öst and associates became interested in the merits of applied tension versus exposure-only 
treatment for blood phobia. Öst, Fellenius, and Sterner (1991) compared the efficacy of 
exposure-only treatment with applied tension and tension-only treatments among patients with 
blood phobia at a psychiatric hospital. The tension-only condition consisted of training in bodily 
cues for a drop in blood pressure and muscle tensing techniques that could be used to reverse this 
drop. The applied tension condition included this training as well as exposure to blood stimuli. 
Thirty participants were randomized to one of the three conditions, resulting in ten participants 
per group. Participants in all conditions improved post-treatment on all outcome measures (self-
report, behavioral, and physiological). However, while there were no group differences in 
physiological measures or self-report measures of fear, the applied tension and tension-only 
groups improved significantly more than the exposure-only group on behavioral measures. As in 
Öst’s earlier work, these behavioral measures consisted of measurements of how long 
participants could watch a video featuring blood stimuli and the therapists’ assessments of 
participant fainting behaviors. The applied tension group also evidenced an advantage in 
Clinically Significant Improvement (CSI; that is, their behaviors improved to a degree that was 
considered clinically meaningful) compared to the exposure-only group. The improvements 
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across all groups were predominantly intact one year later, as was the advantage in CSI for the 
applied tension group over the exposure-only group. These data suggest that combining exposure 
with muscle tensing is superior to exposure alone for blood phobia. 
Beyond the specifics of exposure treatments, Öst and colleagues also investigated the 
effects of the spacing and duration of exposure sessions on the benefits achieved. Öst, Hellström, 
& Kåver (1992) evaluated one versus five sessions of exposure therapy in the treatment of 
psychiatric hospital outpatients with injection phobia. The one session condition consisted of a 
single exposure therapy session that lasted up to three hours. The five session condition consisted 
of five separate sessions of exposure therapy lasting up to one hour apiece. Forty participants 
were distributed evenly between the two conditions via random assignment. Both groups 
improved on physiological, behavioral, and self-report measures. They also evidenced CSI on 
measures assessing behavioral avoidance. These measures consisted of the patients’ progress on 
a 20-step exposure hierarchy and a self-report measure of injection avoidance. All gains were 
roughly equal between the two groups (e.g., 80% of the one session group and 79% of the five 
session group demonstrated clinically significant improvement) and were maintained at one year 
follow-up, indicating equivalence between five discrete sessions of exposure therapy and a 
single, lengthy session. 
More recently, Hirai et al. (2008) provided a test of the efficacy of single exposure 
sessions to BII stimuli. The investigators compared a single-session exposure protocol targeting 
fear versus one addressing fear and disgust (based on research indicating disgust plays a role in 
the etiology of BII phobia [e.g., Olatunji et al., 2012a]). Their sample included 38 undergraduate 
students and community members with subclinical BII phobia. Participants in the fear-only 
condition received psychoeducation and completed a 14 step exposure hierarchy. Examples of 
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items on the hierarchy included holding an open vial of blood, watching a video of a person 
receiving an injection, and injecting an orange with a syringe. Participations in the fear and 
disgust condition received additional psychoeducation about disgust, as well as three additional 
steps on the exposure hierarchy related to disgust (for example, a participant touching her arm 
with the same hand that held the open vial of blood). Participants in both groups demonstrated 
decreased fear, disgust and avoidance of BII stimuli over the course of the exposure session. This 
study provides additional support for the efficacy of single session exposures to BII stimuli. 
Öst and associates’ did not examine the treatment of BII phobia as such, addressing blood 
phobia in two studies and injection phobia in another. If we assume, as per modern diagnostic 
practices (American Psychiatric Association, 2013), that simple phobias for blood and injection 
are both components of an overarching BII phobia, then we can make some limited inferences 
about the use of exposure for BII phobia.  
There is evidence that exposure with the addition of applied tension training may provide 
better results than exposure alone (Öst, Fellenius, & Sterner, 1991). With just one study of ten 
participants receiving exposure-only versus ten receiving exposure plus applied tension training, 
the small sample size limits generalizability. The applied tension training, in part, draws on 
classical conditioning for its theoretical rationale: repeatedly relaxing when presented with the 
feared BII stimulus should lead to the BII stimulus no longer provoking a fear response and 
perhaps even eliciting relaxation. However, similar rationales were used in formulating 
relaxation procedures for the treatment of panic disorder. Recent evidence has suggested the 
applied tension training for panic disorder may actually act as an interoceptive avoidance 
mechanism (see Craske & Barlow, 2007), leading to its exclusion in protocols intended to treat 
panic by authors who previously recommended it (e.g., Barlow et al., 2011). More research is 
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needed to determine if applied tension may perform a similar avoidance function in the treatment 
of BII phobia. 
Exposure by itself seemed to be effective across studies. It led to improvement in all four 
studies and CSI in the two studies in which CSI was calculated. There is some evidence that a 
single, extended session of exposure therapy may function as well as repeated sessions (Öst et 
al., 1992; Hirai et al., 2008). 
Neither exposure protocols for BII phobia nor exposure treatments for general mental 
health problems have considered the role of the peak-end rule in constructing exposure sessions. 
This paper will presently review the role of the peak-end rule in retrospective evaluations of 
events related to BII and health settings. 
Peak-End Rule 
Research regarding retrospective evaluations of unpleasant events confound “logical 
principles” that guide intuitions about how evaluations occur (Kahneman et al., 1993). An 
important example of a “logic”-violating finding concerns the relative unimportance of the 
duration of a distressing event in one’s global evaluation of it (duration neglect) (Kahneman et 
al., 1993). Instead, the evidence indicates that a person’s retrospective evaluation of a distressing 
event is determined by the peak-end rule: the unweighted average of the most distressing part of 
the experience (the peak) and the amount of distress experienced at the event’s conclusion (the 
end) (Fredrickson & Kahneman, 1993).     
Initial work demonstrating the peak-end rule was conducted by Fredrickson and 
Kahneman (1993). They examined the role of event duration in participants’ evaluations of 
affective experiences. Relevant to the use of BII visual stimuli in exposure sessions, their 
investigations utilized visual stimuli of pleasant and unpleasant film clips (e.g., puppy playing 
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with flowers and pigs being beaten to death with clubs, respectively). In their first study, they 
randomized 32 university students into four groups and asked them to provide real-time affective 
(i.e., pleasant or unpleasant) evaluations of different combinations of the clips using a 15-light 
“affect meter.” Participants turned a knob to illuminate colored lights on a video monitor, with 
the seven left-most lights indicating degrees of negative feelings and the seven right-most light 
indicating degrees of positive feelings. Some students saw longer versions of pleasant and 
unpleasant film clips than others. Immediately after each clip ended, students also provided a 
global evaluation of its pleasantness or unpleasantness. Fredrickson and Kahneman found that 
the length of the clips had little effect on students’ global evaluations. Additionally, a student’s 
peak affective rating of a given clip in unweighted combination with her affective rating at the 
end of the clip was a significantly better predictor of her global evaluation than the average of 
her real-time evaluations.  
In their second study, Fredrickson and Kahneman showed pleasant and unpleasant film 
clips to 96 university students. In this instance, the researchers were interested in the effect of 
clip duration on a participant’s global affective rating of a clip if the participant did not make 
ratings until she had viewed all clips. Half of the participants were prompted at the beginning of 
the experiment to notice the effect each clip had on their affect because they would be evaluating 
the clips’ pleasantness and unpleasantness at the end of the trial. The other half of participants 
did not receive this prompt. The researchers found that the former group’s ratings of each clip 
were similar to those in the first study, evidencing little effect for the role of clip duration in 
determining affective experience. However, the effects were even smaller in the group that was 
not told ahead of time to notice their affective experience while watching each clip in preparation 
for later rating them. This group demonstrated more pronounced duration neglect, providing 
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further support for the notion that retrospective ratings of affective experience are determined by 
important affective moments during the experience rather than by the length of the experience. 
The investigators note that the procedures utilized with the latter group probably more closely 
resemble those used outside of laboratory settings. That is, when an individual retrospectively 
evaluates the pleasantness or unpleasantness of an experience it is done on an ad hoc basis, 
rather than with the individual having made a continuous, conscious effort to track affect with 
the intention of providing a global rating of the experience at a later time. 
Of particular importance to medical procedures, Kahneman and colleagues (1993) looked 
beyond pure affect to evaluations of pain. Thirty-two male university students completed two 
trials of pain evaluation. In one trial, subjects immersed one hand in 14°C water for 60 seconds. 
In the other trial, they stuck one hand in 14°C water for 60 seconds, then held it in the water for 
an additional 30 seconds. During the additional 30 seconds, the temperature of the water was 
raised by the experimenters to 15°C. Following the peak-end rule, one would expect the peak of 
pain to be the same for both trials, but for the end experience of pain to be less for the longer 
trial, which concluded with relatively warmer water. Participants’ retrospective moment-to-
moment ratings of the trials evidenced these expected differences in pain. After completing both 
trials, participants were told that they would choose which of the two trials to repeat (they 
ultimately did not actually repeat either one) and were asked about their experiences of them. 
Sixty-nine percent of participants preferred to repeat the longer trial as opposed to the shorter 
trial. Additionally, participants rated the longer trial more favorably than the shorter trial on 
Likert scale items (e.g., “Which trial caused the greater overall discomfort?”). The subjects 
correctly assessed the longer trial as lasting a greater period of time than the shorter trial, yet they 
still preferred it. If participants had intended to decrease their total exposure to pain, they would 
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have selected to repeat the objectively shorter trial. That they did not do so and that they rated 
the longer trial more favorably than the shorter suggests a significant role for the peak-end rule in 
affective evaluations.   
 Redelmeier and Kahneman’s (1996) study provides further insight on the potential 
importance of the peak-end rule to medical procedures. Participants were 154 patients 
undergoing colonoscopy and 133 patients undergoing lithotripsy at a Canadian hospital. Patients 
reported real-time evaluations of the pain they were experiencing every one minute via an 
analogue scale on a hand-held device. Subsequently, they retrospectively rated their experience 
of the pain on a 10-point scale. The colonoscopy patients provided an additional retrospective 
rating one month later and the lithotripsy patients provided an additional rating one year later. 
Physicians also provided assessments immediately after the procedures of how much pain they 
thought they patients would indicate they had experienced, as well as whether they would have 
administered more anesthetic if they were to redo the procedures. Retrospective pain ratings did 
not significantly correlate with the length of the procedures, an example of relative duration 
neglect. However, retrospective ratings were significantly correlated with the peak pain ratings 
reported for the procedures, as well as the ratings provided in the last three minutes of the 
procedures. Additionally, both physicians’ estimations of patients’ pain ratings and their 
judgments related to anesthesia levels were significantly correlated with patients’ peak and end 
pain ratings, not the durations of the procedures. The conclusions that one can draw from the 
study, though, are limited by its correlational nature.  
 Redelmeier, Katz and Kahneman (2003) followed-up with a study of the peak-end rule in 
a medical setting using an experimental design. Six hundred-eighty-two patients receiving a 
colonoscopy were randomized to one of two conditions. In one, they received the procedure as it 
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is conventionally administered, with the removal of the colonoscope at the end of the 
colonoscopy. In the other, after the colonoscopy was finished (that is, no more suction, inflation, 
etc.), physicians rested the tip of the colonoscope in patients’ rectums up to three minutes prior to 
removal. Participants rated their real time experiences of pain during the procedure on a 
thermometer displayed on a handheld device. They also provided retrospective ratings, both in 
terms of their overall amount of discomfort and with regard to how the experience compared to 
other unpleasant life experiences. Additionally, as a measure of adherence, the researchers 
tracked for close to six years after the start of the investigation whether participants received a 
second colonoscopy after the original colonoscopy. Results indicated benefits for the longer 
procedure across the board. As hypothesized, patients who had the colonoscope remain in them 
for additional time reported the final moments of the procedure as less painful. They 
subsequently rated their overall experience as less discomforting and compared it more favorably 
to other unpleasant life events. Of particular note for practical implications, they were more 
likely to undergo a second colonoscopy.  
Finn (2010) demonstrated applicability of the peak-end rule to learning under difficult 
circumstances (as one would expect learning to be during exposure to a feared stimulus). Across 
two studies, Finn used procedures similar to those of Kahneman et al.’s (1993) experiment, but 
with a learning task in place of exposure to cold temperatures. The learning task involved two 
lists of Spanish-to-English translations that 44 participants were asked to memorize with the 
belief that they would be quizzed over the 20 toughest items from each list. The Short list 
consisted of 30 extremely difficult translations. The Extended list consisted of 30 equally 
difficult translations, followed by 15 translations of moderate difficulty. Twenty-one randomly 
assigned participants completed the Extended list followed by the Short list, as well as quizzes 
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for each, while 23 participants completed the lists and quizzes in the opposite order. Participants 
were then asked which type of list they would prefer used during a third test/quiz combination 
that they believed they would be completing that day. They were also asked which type of list 
they would prefer to complete if they were hypothetically returning for a second day of 
experimentation. Additionally, participants rated the difficulty of each list, how long each took to 
learn, how much discomfort they experienced with each, and how tough it was to cope with 
each. Impressively, across all measures, participants favored the Extended list to a statistically 
significant degree.  
 Finn’s (2010) second study used the same procedures as the first experiment, except that 
participants provided real time evaluations of their ratings of discomfort. This tested the 
possibility that participants preferred the Extended list because they found learning moderately 
difficult translations non-aversive or even enjoyable. Conversely, if participants rated the 
moderately difficult translations as aversive, yet still preferred the Extended list, this would 
provide further support for the peak-end rule. Participants did in fact rate the moderately difficult 
translations as aversive (albeit less so than the extremely difficult translations), while still 
expressing statistically significant preferences for the Extended list. Taken together, Finn’s 
studies indicate that the peak-end rule may apply to difficult learning broadly considered, not just 
in situations related to physical pain or discomfort. 
 Experimental research demonstrates the influence of peak-end rule in shaping 
retrospective evaluations of affective experiences. The data reviewed support its applicability to 
a variety of situations, including the viewing of pleasant and unpleasant images, evaluations of 
pain, evaluations of and willingness to undergo subsequent medical procedures, and learning 
under difficult circumstances. These findings are potentially relevant for treating BII phobia with 
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exposure therapy. Exposure treatment involves viewing stimuli that persons with BII phobia find 
unpleasant. It also entails learning under difficult circumstances. Specifically, exposure treatment 
involves basic learning (habituation to a phobic stimulus) and more complex learning (the 
individual realizes that she can experience symptoms of fear or disgust, or even faint, without 
catastrophic consequences). Additionally, applications of the peak-end rule to medical 
procedures are likely to generalize to BII phobia. This is the case both for the stimuli used during 
exposure treatment (e.g., an individual injecting a mock arm with a syringe or viewing a photo of 
an injury) as well as for therapeutic outcomes (e.g., does a person visit the dentist post-
treatment?). Similar to patients’ experiences with colonoscopies, lowering the peak-end average 
could lead to lower distress associated with exposure sessions, better adherence to exposure 
protocols, and thus, better medical outcomes. 
More research addressing the particulars of how the peak-end rule may affect the efficacy 
of exposure therapy for BII phobia is needed. An empirical study directly testing one 
permutation of the peak-end rule on exposure therapy is the focus of the next section. 
Present Study  
 In the extant literature, exposure therapy experiments have involved exposure to 
increasingly fearful stimuli over the course of the sessions. If a clinician’s goal, though, is to 
increase patients’ adherence to exposure therapy so that they complete multiple trials, then the 
present format of exposure treatment may not be ideal. When participants face a fearful stimulus 
and habituate to it, the experience will likely still be unpleasant. If it is too unpleasant, the 
participant may be less likely to return for additional exposure sessions.  
For example, Tyrone, a hypothetical patient with BII phobia, constructs an anxiety 
hierarchy with his therapist. He rates various BII-related behaviors (e.g., injecting an orange with 
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a syringe) on a 10-point SUDs scale. He completes an exposure for holding a syringe, which he 
rated as a 9 on his hierarchy prior to the exposure. At the end of the exposure, he rates the 
experience as a 7 in terms of the distress it causes. From the standpoint of exposure therapy as it 
is usually completed, Tyrone’s experience is a success. He has habituated to the experience 
enough that on that day, he does not feel as much fear around the stimulus as he did before the 
session. However, a 7 out of 10 may still represent a significant amount of distress; perhaps 
enough distress for Tyrone to engage in avoidance and skip his future appointments. The peak-
end rule offers a potential remedy for this problem.   
 Exposure sessions which utilize the peak-end rule might end with the participant facing a 
stimulus that she considers less distressing than the one she faced immediately prior to it. Note 
that this does not mean the patient avoids the stimuli that prompt the most anxiety. It simply 
entails an additional exposure trial for after exposure to one of the stimuli that causes high 
anxiety. Per the peak-end rule, the retrospective evaluation of the session should be influenced 
significantly by how it concluded (the end). As such, if the session ends with an exposure to a 
stimulus that is not at the top of the hierarchy, the exposure therapy session will be less likely to 
be perceived as highly distressing and the patient will be more likely to continue receiving 
treatment. 
In the hypothetical scenario with Tyrone, the therapy session would not conclude as soon 
as Tyrone’s distress lowered from a 9 to a 7 when holding a syringe. Rather, Tyrone would finish 
therapy with exposure to a stimulus lower on his hierarchy, such as looking at a cartoon picture 
of a needle, which he rated at a 4 in terms of SUDs. Tyrone proceeds to habituate to the cartoon, 
eventually rating his distress level at a 3. His retrospective evaluation of the session is more 
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favorable than it would have been had he ended with the exposure to the more distressing 
stimulus. Tyrone might be more likely to keep his next appointment. 
The present study attempted to assess the role of the peak-end rule in improving the 
acceptability of and adherence to exposure protocols for BII phobia. The investigator examined 
the effect that decreasing the aversive nature of the stimuli viewed at the end of a BII exposure 
session had on global retrospective evaluations of the session. It was hypothesized that 
participants who view several less aversive stimuli at the end of the session would 
retrospectively rate the session as less aversive, rate themselves as more willing to complete a 
hypothetical second exposure session, and ask for less money to complete a hypothetical second 




 The University of Kansas Institutional Review Board approved this study. Participants 
were recruited using Amazon.com’s Mechanical Turk (MTurk) service. Evidence suggests that 
MTurk participants are more representative of the U.S. population than convenience samples 
frequently used in social science research (Berinsky, Huber & Lenz, 2012; Buhrmester, Kwang 
& Gosling, 2011). MTurk workers were eligible for the study if they were 18 years old or older, 
fluent in written English and indicated that they did not become dizzy or faint when presented 
with images of blood, injections, or injuries. Each worker was offered $1.50 as compensation for 
participation. 
Sample Size Calculation 
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The investigator conducted a power analysis using G*Power 3.1.7 (Faul, Erdfelder, Lang 
& Buchner, 2007). It indicated that a sample size of 176 participants would have 80% power to 
detect a difference, assuming a small effect size (f = .1) using an independent t-test with a 0.05 
significance level. The investigator conservatively assumed a small effect size due to the novelty 
of applying the peak-end rule to exposures. 
Procedures 
A total of 201 participants were recruited via MTurk. Each participant was asked to log 
on to a website featuring the Qualtrics (Provo, Utah) survey software to look at pictures of BII. 
Participants provided basic demographic information and completed the Medical Fear Survey-
Short Version (Olatunji et al., 2012b), which assessed their BII anxiety. Following this, the 
website explained the concept of Subjective Units of Distress (SUDs) and asked them to rate 
their pre-trial SUDs about looking at pictures of BII. Participants were then exposed to 12 severe 
photos of blood and injuries which the investigator selected from the International Affective 
Picture System (IAPS; Lang, Bradley & Cuthbert, 2008). The IAPS photos were presented in 
order of increasing severity (as determined by their IAPS normed arousal ratings). Photos were 
presented to participants for five seconds apiece. After each photo, participants rated the 
maximum amount of SUDs they experienced while viewing the photo. Three additional, less 
severe photos of blood and injuries (e.g., a scraped knee) were selected from Flickr.com and 
inserted among the IAPS photos to serve as a validity check; a higher average distress rating for 
these photos than the IAPS photos would likely indicate a participant had not paid attention to 
the photos presented. 
Half the participants (the “regular end” group) were randomized to have their viewing 
session end at the conclusion of the fifteenth and most severe photo. They provided a 
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retrospective global SUDs assessment of their viewing experience, indicated their hypothetical 
willingness to view more BII photos, and reported how much hypothetical money they would 
require to complete a second exposure session. They also answered an exploratory question 
concerning their distress at that moment. The other half of the participants received the “better 
end,” viewing and rating three additional, less severe photos for five seconds apiece. These three 
photos were also selected from Flickr.com. The better end group then completed the same post-
viewing outcome measures as the regular end group. Following this, participants were debriefed.  
Table 1 displays the procedures for both groups in sequential order. 
Measures 
 Demographic data. The investigator collected information regarding participants’ 
gender, age, ethnicity and family income.  
 Medical Fear Survey-Short Version (MFS-SV). Participants’ baseline distress 
concerning BII stimuli was assessed using the MFS-SV. The MFS-SV consists of 25 items 
across five subscales, measuring medical fears related to Injections and Blood Draws, Sharp 
Objects, Blood, Mutilation, and Examination and Symptoms. The internal consistency alpha 
coefficients of its five subscales range from .81 to .89. The subscales also evidence acceptable 
levels of convergent validity with measures of injection fear, fearfulness and disgust sensitivity 
(mean r = .53), as well as acceptable levels of discriminant validity with measures of anxiety 
sensitivity and trait anxiety (mean r = .35) (Olatunji et al., 2012b). 
 Pre-viewing distress. Participants’ baselines distress about viewing BII stimuli was also 
measured using a 0-8 SUDs scale (the same SUDs scale used in Barlow et al., 2011). The “0” 
was labeled as “no distress,” the “2” as “slight distress,” the “4” as “definite distress,” the “6” as 
“strong distress,” and the “8” as “extreme distress.” SUDs evidences acceptable concurrent 
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validity with the State/Today Form of the Multiple Affect Adjective Check List, a measure of 
state anxiousness (r = .53) (Kaplan & Smith, 1995). 
 Average distress for first 15 images. Participants’ distress while viewing the first 15 
photos was assessed using SUDs ratings. After each photo, participants rated their SUDs on the 
same 0-8 scale described previously. From each participant’s ratings of the 15 photos, the 
investigator derived a mean rating that served as that participant’s average distress score for 
these images.  
Primary outcome measure: Retrospective global assessment of distress. After viewing 
all images (15 for the regular end group and 18 for the better end group), participants 
retrospectively rated their overall level of distress associated with the exposure session on a 0-8 
SUDs scale. 
 Secondary outcome measure: Willingness to complete hypothetical second session. 
After the end of the exposure session, participants rated on a 0-8 Likert scale how willing they 
would be to complete a hypothetical second session. The labels on the Likert scale were similar 
to those used for the SUDs scales (e.g., “0” was labeled as “not willing”).   
Secondary outcome measure: Payment required for hypothetical second session. After 
the end of the exposure session, participants indicated how much money ($) they would need to 
complete a hypothetical second session.   
Exploratory outcome measure: Current distress. After the end of the exposure session, 






Demographics between groups were compared using either an independent t-test (for 
age) or chi-squared tests (for gender, ethnicity, and family income). No significant differences 
were detected with respect to gender, age, ethnicity, and family income. Table 2 presents these 
data. 
Baseline comparison 
Independent t-tests were used to assess for baseline differences between groups on MFS-
SV scores and pre-viewing distress ratings. There were no significant baseline differences on 
MFS-SV scores; t (199) = .55, p = .586, or on pre-viewing distress ratings; t (199) = .34, p = 
.735. Table 3 displays these data. 
Average distress for first 15 images 
Average distress ratings for the first 15 pictures were analyzed using an independent t-
test to detect any differences between groups prior to their randomization to different endings. 
There were no significant differences between groups for their average distress for the first 15 
images; t (199) = 1.18, p = .240. Table 4 presents these data. 
Primary outcome measure: Retrospective global assessment of distress 
 Differences on the retrospective global assessment of distress were assessed between 
groups using an independent t-test. The better end group rated the session as significantly less 
distressing with a medium effect size; t (199) = 3.54, p <.001, d = .50. Table 5 displays these 
data. 
Secondary outcome measure: Willingness to complete hypothetical second session 
Participants’ ratings of their hypothetical willingness to view additional BII images were 
analyzed between groups with an independent t-test. There were no significant differences 
between groups on willingness; t (199) = 1.42, p = .158, d = .20. Table 5 presents these data. 
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Secondary outcome measure: Payment required for hypothetical second session 
The payments ($) participants’ indicated they would hypothetically require to view 
additional BII photos were compared between groups using an independent t-test. Five answers 
that were uninterpretable (e.g., one participant wrote “Depends on the amount of photos”) were 
excluded from the analysis. Eighteen outliers were also excluded on the basis of Tukey’s (1977) 
interquartile criteria. There were no significant differences between groups on hypothetical 
money required; t (176) = 1.25, p = .214, d = .19. Table 5 displays these data. 
Exploratory outcome measure: Current distress 
An independent t-test was utilized to compare between groups on participants’ 
assessments of their distress at the end of the experiment. One participant did not answer the 
question. The better end group endorsed lower distress. The effect size was small; t (198) = 2.56, 
p = .011, d = .36. Table 5 presents these data. 
 
Discussion 
 This study assessed the effect of the peak-end rule on evaluations of exposure to BII 
stimuli. The results supported the primary hypothesis. Participants who viewed less severe 
photos at the end of the session retrospectively rated it as less distressing. The results did not 
support the two secondary hypotheses. Participants who received the “better end” were not more 
willing to view hypothetical additional photos. They also did not report that they would require 
less money to view said hypothetical photos. However, the better end group did indicate they 
experienced less distress at the end of the experiment.  
 This investigation represents a novel application of the peak-end rule to exposure 
therapy. Previous studies examined, for instance, retrospective evaluations of pleasant and 
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unpleasant film clips of a sometimes graphic nature (Fredrickson & Kahneman, 1993) and an 
aversive procedure experienced within a health context (colonoscopy; Redelmeier, Katz, & 
Kahneman, 2003). However, this is the first attempt to apply the peak-end rule to a clinical 
psychological phenomenon, and the results are consistent with the broader peak-end rule 
literature.  
 While the experiment’s results are encouraging, they are tempered by several limitations. 
Most notably, the study’s population was not drawn from a clinical sample of persons with BII 
phobia. While it is possible some MTurk workers who saw the listing for the study have BII 
phobia, it is unlikely that a financial incentive of $1.50 was sufficient for them to expose 
themselves to their phobic stimuli. Furthermore, as a safety precaution, those who become dizzy 
or faint upon viewing BII stimuli – such as those with BII phobia – were specifically excluded 
from participating in the research. Consequently, the results obtained here may not generalize to 
a population with BII phobia participating in actual therapeutic exposure sessions; they may 
accordingly lack in clinical utility. 
Data from the secondary outcome measures deal an additional blow to the clinical 
meaningfulness suggested by the findings from the primary outcome measure; the severity of the 
blow, though, is uncertain. Participants who viewed less severe photos at the end of the 
experiment neither evidenced increased willingness nor indicated they would require less money 
to view more BII photos. These secondary outcome measures required participants to “look 
forward” and consider participation in future hypothetical exposure sessions – not unlike actual 
clients undergoing exposure therapy. However, aside from this consideration, the clinical 
relevance of the secondary outcome measures is unclear. Actual exposure therapy clients are 
rarely paid for participating in therapy or asked how much money they would require to 
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participate.2 Similarly, actual clients are, in part, motivated to participate in exposure sessions by 
the prospect of improvement of their mental health; participants in the present study had no 
similar motivation to continue looking at BII stimuli, and this may have moderated their reported 
willingness to do so. 
  Results from the exploratory outcome measure regarding current distress also muddy 
the clinical utility waters. The better end group was less distressed at the end of the experiment, a 
potential indication that a less severe end to exposure sessions lowers not just retrospective 
evaluations of distress but distress in the present moment. However, since this outcome measure 
was included purely on an exploratory basis (i.e., with no hypothesized difference between 
groups), it cannot be weighted as heavily as the other outcome measures in evaluations of the 
clinical relevance of the study’s findings.  
A final question of utility concerns the relative importance of end-of-session distress to 
therapeutic exposure outcomes. While traditionally assumed to be important in exposure therapy 
protocols, a review by Craske et al. (2008) indicated that anxiety ratings at the end of exposure 
sessions are unrelated to improvement. If the findings from Craske and colleagues (2008) are 
replicated, then the importance of the preliminary data from the present experiment is greatly 
diminished.  
 In addition to questions regarding the results’ clinical meaningfulness, the interpretation 
of the findings presented here assumes that participants’ retrospective evaluations were in fact 
determined by the peak and end affective experiences of the exposure session. However, 
participants’ peak and end ratings were not tracked in real-time, as has been the case in some 
                                                          
2 Though the question was phrased as a hypothetical, MTurk workers may have also suspected that the experimenter 
was asking how much money they would require to look at more photos as a prelude to his offering another MTurk 
experiment. This inference could have artificially inflated their responses; mean answers for both groups ($3.79 for 
the regular end and $3.29 for the better end, respectively) were greater than the $1.50 participants were paid. 
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other peak-end experiments (e.g., Fredrickson & Kahneman, 1993). As such, it is possible that 
other factors may have determined their retrospective ratings of the session.  
Given the promising data from the primary outcome measure, future experiments should 
ascertain if the study’s results replicate with a population with BII phobia. Similar findings 
would justify exploring applications of the peak-end rule to actual exposure sessions with clients 
with BII phobia and other anxiety disorders. This would determine if exposure therapy informed 
by the peak-end rule could provide important “better ends,” producing clinically significant 
improvements in adherence to therapy, pursuance of standard medical care, and adherence to 
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Table 2: Demographic Data 
  
Group 1 (regular 
ending) 
Group 2 (less 
severe photos at 
end) 
 
n M or % n M or % df p 
Gender (male) 64 58.71% 47 51.08% 1 .279 
Age 109 33.70 92 34.03 199 .827 
Ethnicity 109  92  6 .439 
 American 
Indian / Native 
American 
- - 1 1.1%   
 Asian / Asian 
American 
5 5.6% 2 2.2%   
 Black / African 
American 
9 8.3% 6 6.5%   
 Hispanic / 
Latino 
7 6.4% 5 5.4%   
 White / 
Caucasian 
88 80.7% 75 81.5%   
 Pacific Islander - - 1 1.1%   
 Other - - 2 2.2%   
Family Income  109  92  7 .783 
 Under $25,000 20 18.3% 14 15.2%   
 $25,000 to 
$39,000 
40 36.7% 29 31.5%   
 $40,000 to 
$49,999 
9 8.3% 13 14.1%   
 $50,000 to 
$74,999 
17 15.6% 19 20.7%   
 $75,000 to 
$99,999 
17 15.6% 12 13.0%   
 $100,000 to 
$124,999 
2 1.8% 1 1.1%   
 $125,000 to 
$150,000 
2 1.8% 3 3.3%   





Table 3: Baseline Data 
 Group 1 (regular ending) Group 2 (less severe 
photos at end) 
 
 n M SD n M SD t df p 
MFS-SV 
scores 










Table 4: Average Distress for First 15 Images 















Table 5: Outcome Data 
 Group 1 (regular 
ending) 
Group 2 (less 
severe photos at 
end) 
 
 n M SD n M SD t df P d 
Overall, how 
distressing did you 
find the 
experience of 
looking at the 
photos? 
109 5.47 2.32 92 4.33 2.22 3.54 199 <.001 .50 
Hypothetically, 
how willing would 
you be to view 
more photos like 
these? (Note: Your 
answer 
will not affect the 
length of the 
experiment.) 
109 3.50 2.52 92 4.00 2.50 1.42 199 .158 .20 
Hypothetically, 
please indicate 
how much money 
($) you would 
need to be paid to 
view more photos 
like these. (Note: 
Your answer 
will not affect the 
length of the 
experiment.) 
92 3.79 2.86 86 3.27 2.66 1.25 176 .214 .19 
At this moment, 
how 
much distress are 
you feeling? 
109 4.08 2.40 91 3.26 2.06 2.56 198 .011 .36 
 
 
 
 
